A complete reversal of last week, with OPTI:Optibiotix recovering all losses whereas my other shares didn't fare so well. The result was an increase in value of £10,958 to go back into profit by £1,218 and increase overall portfolio and cash value to £130,782.
Worst performer was ITX:Itaconix, but that's because I doubled my
holding and effectively halved the percentage gain. It fell by 38% but is
still 38% up as it had been 76% up which was flat with last week. I'm
fairly staggered with the number of products they are in, and even though
there are some red flags in the finances, the profits that will come from
being in so many products ought to sort them out.I bought 7,440 shares at
6.72p costing £508.92.
Next worst performer was FXPO:Ferrexpo which dropped 11%. That's on the
back of a 5% drop last week. However, I noticed on my account that they went
ex-dividend on 14th January for a special dividend which will be paid next
Thursday, so some of the sell off could be those getting out after qualifying
for the dividend.A bit of a bonus as I didn't spot the announcement in the
last trading update. It should be worth about £36.
Unfortunately my next worst performer was CAML:Central Asia Metals, dropping 6% after a 16% fall last week. I can only assume this is traders taking profits after the recent massive rise, but unfortunately it happened just before my trading account holding was high enough to sell. I guess I can wait a few more weeks.
The final big faller this week was ITV:ITV which lost 5%. I suspect this is another case of people selling due to the recent sustained rise. They are still 49% up so I'm happy with that. Re-instatement of the dividend would be my main wish because magic formula shares are meant to earn dividends. I've already had around £250 dividends from the combined magic formula portfolio in the last six months which is 3.6% of the £7,000 and way better than I'd get in a building society.
CMCL:Caledonia Mining actually dropped this week, but I invested another £1,000 buying 87 shares at 1,137.5p costing £998.58. By doubling my holding in a loss making share I effectively halved my deficit from 23% down to only 13%. This was part of me blowing all the cash I had reserved for SBTX:SkinBioTherapeutics when their share price went crazy and it became clear they would not be back at my preferred price for some time. I'm not holding cash that long so put it into shares I think are about to rally. CMCL have a P/E ratio of 4.2 which is utterly crazy given they are paying increasing monthly dividends, the next one of which is due for payment on Friday after going ex dividend on Thursday. I missed it by a day with the new shares but got a good price.
IQE:IQE have been gradually sneaking up and climbed another 13% this week. My ISA holding is now 14% up and making £304 potential profit. This is now my SBTX:SkinBioTherapeutics pot. I'll sell at around 100p and hold the cash for when SBTX drops back to 20p.
Share of the Week is OPTI:Optibiotix which gained back all of last week's 9p drop to climb by 14% back into profit of £500. I got so excited by the bullish signals coming from chartists and from the bottleneck of news predicted to break over the next few months that I used half my SBTX:SkinBioTherapeutics cash to buy another 3,032 at 65.9454p costing £2,008.41. This is the first time in a very long time that I have slightly increased my average price, but only by a fraction as my average is around 64p.The purchase took my holding to just over 130,000 shares.
The red line went back up due to re-investing the cash and the green line is now above it - huzzah!
Granted we're only just over the zero line...
Here's the ISA and shares portfolio after week 25 of year 6
| Weekly Change | |||
| Cash |
£32.95 |
+£0 | |
| Portfolio cost | £63,009.29 | +£0 | |
| Portfolio sell value (bid price-commission) | £63,719.28 | (1.1%) | +£6,759.13 |
| Potential profits | £9,903.61 | +£1,211.95 | |
| Yr 6 Dividends | £0 | +£0 | |
| Yr 6 Profit from sales | £591.81 | +£0 | |
| Yr 6 projected avg monthly profit | £98.68 | (2.8%) | -£4.11 |
| Total Dividends | £1,343.15 | +£0 | |
| Total Profit from sales | £21,018.42 | +£0 | |
| Average monthly cash profit | £336.12 | (9.7%) | -£1.18 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 53% | +0% |
Fairly quiet apart from the big surge from OPTI:Optibiotix. Both sell
value and potential profits are up slightly less than they fell last week,
mainly thanks to a 2% drop for JLP:Jubilee Metals.
Not a record high, but back on the right side of the red line which I thought might take longer than this to achieve after the massive drop last week.
I shudder to think what will happen next week...
The SIPP looks like this after week 269 overall and week 9 of year 6.
| Weekly Change | ||||
| Cash | £285.93 | -£4,523.75 | ||
| Portfolio cost | £63,621.21 | +£4,527.75 | ||
|
Portfolio sell value (bid price - commission) |
£64,538.70 | (1.4%) | +£4,194.84 | |
| Potential profits | £4,920.46 | -£705.41 | ||
| Yr 6 Dividends | £378.23 | +£0 | ||
| Yr 6 Interest | £0 | +£0 | ||
| Yr 6 Profit from sales | £2,172.89 | +£0 | ||
| Yr 6 projected avg monthly profit | £1,212.27 | (36.3%) | -£151.54 | |
| Total Dividends | £2,445.31 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £17,632.33 | +£0 | ||
| Average monthly cash profit | £312.90 | (9.4%) | -£1.16 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 48% | +0% |
Nearly all the cash was piled into shares, and the value went up by an extra £4,194 on top of that. OPTI:Optibiotix is still loss making in this account so didn't contribute enough to profits to mitigate the drop of CAML:Central Asia Metals, FXPO:Ferrexpo and ITV:ITV.
I've already mentioned the purchases in ITX:Itaconix, OPTI:Optibiotix and CMCL:Caledonia Mining. I also bought some more DDDD:4D Pharma as I think they could have a significant re-rate after the Nasdaq listing. I may top slice some of these to get back to £4K worth of SBTX:SkinBioTherapeutics if they ever drop in price again, but I really want a decent amount of DDDD to hold long term. I bought 861 shares at 116.0152p costing £1,007.84. My combined holding is down by 8% but hopefully not for long.
This account has just about managed to stay above the green line on this chart thanks to last week's big cash buffer.
This chart didn't have the benefit of cash, and is also quite revealing that we're not in anywhere near as good shape as we were 2 weeks ago.
The trading account looks like this after week 235 overall and week 27 of year 5
| Weekly Change | |||
| Cash | £249.58 | +£0 | |
| Portfolio cost | £2,364.43 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,955.93 | (-17.3%) | +£4.34 |
| Potential profits | £0 | +£0 | |
| Year 5 Dividends | £12.18 | +£0 | |
| Year 5 Profit | £631.65 | +£0 | |
| Yr 5 projected avg monthly profit | £103.33 | (52.4%) | -£3.98 |
| Dividends | £60.10 | +£0 | |
| Profit from sales | £918.02 | +£0 | |
| Average monthly cash profit | £18.04 | (9.2%) | -£0.07 |
|
(Sold stocks profit + Dividends - Fees / Months) |
Just about as flat as it can get, with a rise in IQE:IQE offset by a drop in CAML:Central Asia Metals. The non-suspended shares are down by 4%, 9%, 16% and 20% with HUM:Hummingbird Resources the one nearest to breaking into profit.
If OPTI:Optibiotix goes on a charge, then I very much look forward to doubling the amount of money in this account and having 10 holdings on the go at once. I really need to get to the point where I'm selling one a week.
If I can hold the green line at this level while the orange line continues to drop as I extract profits, then I'll be very happy indeed.
A long recovery, but definitely a recovery.
So we're back where we were 2 weeks ago and in profit. Happy days that were very short lived last time. Will we see the same happen again or will we hold in profit next week? OPTI:Optibiotix has been pushing at the door for a very long time now, as deal after deal was made. I've always believed that it would break out one day, and when it does the breakout could be spectacular, especially after being held in this trading range for so long.
If we hadn't have got ahead of ourselves a few years ago and rocketed to 132p I think we would have been on a very gradual climb to 100p by now. That feels like the right price for where we are at the moment given the rapid rate of revenue growth and large pipeline of products being developed with global markets.
Let's hope our time has finally come to fly!
No comments:
Post a Comment